Vitreo Retinal Surgery Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$4000
Buy Report Download FREE Resources

Published: July 16, 2024 Report Code: GDME1780EPD-ST

Select Item

Vitreo Retinal Surgery Devices Pipeline Market Report Overview

Vitreo retinal surgical devices are used for surgical procedures that treat eye problems involving the retina, macula, and vitreous fluid.

The vitreo retinal surgery devices pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Territories ·       The US

·       Europe

·       China

·       Australia

·       India
Key Regulatory Paths ·       510(k)

·       CE

·       NMPA

·       PMA

·       Shonin
Leading Companies ·       ABVC BioPharma Inc

·       AcuSurgical SAS

·       Al.chi.mi.a. Srl

·       Alcon Inc

·       Bausch & Lomb Inc
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Vitreo Retinal Surgery Devices Pipeline Market Segmentation by Territories

A few of the key territories with the vitreo retinal surgery devices pipeline market are the US, Europe, China, Australia, and India. As of July 2024, the US accounts for the highest number of pipeline products.

Vitreo Retinal Surgery Devices Pipeline Market Analysis by Territories, 2024 (%)

Vitreo Retinal Surgery Devices Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Vitreo Retinal Surgery Devices Pipeline Market

Download a Free Report Sample

Vitreo Retinal Surgery Devices Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the vitreo retinal surgery devices pipeline products market are 510(k), CE, NMPA, PMA, and Shonin. As of July 2024, 510(k) is the most followed pathway for pipeline products in the vitreo retinal surgery devices market.

Vitreo Retinal Surgery Devices Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Vitreo Retinal Surgery Devices Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Vitreo Retinal Surgery Devices Pipeline Market

Download a Free Report Sample

Vitreo Retinal Surgery Devices Pipeline Market – Competitive Landscape

A few of the key companies associated with the vitreo retinal surgery devices pipeline market are ABVC BioPharma Inc., AcuSurgical SAS, Al.chi.mi.a. Srl, Alcon Inc., and Bausch & Lomb Inc., among others.

Alcon Inc: Alcon is headquartered in Fribourg, Switzerland. It is engaged in the development and manufacturing of devices in the field of ophthalmology. The company’s portfolio encompasses contact lenses and surgical products, including implantables, consumables, and surgical equipment. The company’s products are indicated for the treatment of various conditions such as cataracts, glaucoma, retinal diseases, and refractive errors. The company has operations in the Americas, Europe, the Middle East, and Africa, and Asia Pacific.

Bausch & Lomb Inc: Bausch & Lomb is headquartered in Bridgewater, New Jersey, the US. It is a vision-care company with focus on the protection, enhancement, and restoration of eyesight. The company develops, manufactures, and markets eye health products for the treatment of a wide range of eye conditions such as conjunctivitis, glaucoma, eye allergies, dry eye, and retinal diseases. It has presence across the Americas, Europe, the Middle East, and Africa and Asia-Pacific.

Vitreo Retinal Surgery Devices Pipeline Market Analysis by Companies, 2024

Vitreo Retinal Surgery Devices Pipeline Market Analysis by Companies, 2024

Buy the Full Report for More Company Insights into the Vitreo Retinal Surgery Devices Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Vitreo Retinal Surgery Devices Pipeline Market Territories Outlook (2024)

  • The US
  • Europe
  • China
  • Australia
  • India

Vitreo Retinal Surgery Devices Pipeline Market Regulatory Paths Outlook (2024)

  • 510(k)
  • CE
  • NMPA
  • PMA
  • Shonin

Scope

This report provides:

  • Extensive coverage of the vitreo retinal surgery devices under development.

  • Exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.

  • Reviews of major players involved in the development of vitreo retinal surgery devices and lists all their pipeline projects.

  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.

  • Key clinical trial data of ongoing clinical trials specific to pipeline products.

  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.

  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.

  • Identify and understand important and diverse types of vitreo retinal surgery devices under development.

  • Develop market-entry and market-expansion strategies.

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.

  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

ABVC BioPharma Inc
AcuSurgical SAS
Al.chi.mi.a. Srl
Alcon Inc
Bausch & Lomb Inc
Beaver-Visitec International Inc
Boston College
Cambridge Polymer Group Inc
Carnegie Mellon University
Duke University
Hangzhou Xiran Medical Equipment Technology Co Ltd
Johns Hopkins University
Medisse BV (Inactive)
RetinaSense
Synergetics USA, Inc. (Inactive)
The Chinese University of Hong Kong
Tupai (Beijing) Medical Technology Co Ltd
University of Kansas
University of Minnesota

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 8

2 Introduction 9

2.1 Vitreo Retinal Surgery Devices Overview 9

3 Products under Development 10

3.1 Vitreo Retinal Surgery Devices – Pipeline Products by Stage of Development 10

3.2 Vitreo Retinal Surgery Devices – Pipeline Products by Territory 11

3.3 Vitreo Retinal Surgery Devices – Pipeline Products by Regulatory Path 12

3.4 Vitreo Retinal Surgery Devices – Pipeline Products by Estimated Approval Date 13

3.5 Vitreo Retinal Surgery Devices – Ongoing Clinical Trials 14

4 Vitreo Retinal Surgery Devices – Pipeline Products under Development by Companies 15

4.1 Vitreo Retinal Surgery Devices Companies – Pipeline Products by Stage of Development 15

4.2 Vitreo Retinal Surgery Devices – Pipeline Products by Stage of Development 16

5 Vitreo Retinal Surgery Devices Companies and Product Overview 17

5.1 ABVC BioPharma Inc Company Overview 17

5.1.1 ABVC BioPharma Inc Pipeline Products & Ongoing Clinical Trials Overview 17

5.2 AcuSurgical SAS Company Overview 18

5.2.1 AcuSurgical SAS Pipeline Products & Ongoing Clinical Trials Overview 18

5.3 Al.chi.mi.a. Srl Company Overview 21

5.3.1 Al.chi.mi.a. Srl Pipeline Products & Ongoing Clinical Trials Overview 21

5.4 Alcon Inc Company Overview 22

5.4.1 Alcon Inc Pipeline Products & Ongoing Clinical Trials Overview 22

5.5 Bausch & Lomb Inc Company Overview 26

5.5.1 Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview 26

5.6 Beaver-Visitec International Inc Company Overview 37

5.6.1 Beaver-Visitec International Inc Pipeline Products & Ongoing Clinical Trials Overview 37

5.7 Boston College Company Overview 38

5.7.1 Boston College Pipeline Products & Ongoing Clinical Trials Overview 38

5.8 Cambridge Polymer Group Inc Company Overview 39

5.8.1 Cambridge Polymer Group Inc Pipeline Products & Ongoing Clinical Trials Overview 39

5.9 Carnegie Mellon University Company Overview 40

5.9.1 Carnegie Mellon University Pipeline Products & Ongoing Clinical Trials Overview 40

5.10 Duke University Company Overview 41

5.10.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 41

5.11 Hangzhou Xiran Medical Equipment Technology Co Ltd Company Overview 42

5.11.1 Hangzhou Xiran Medical Equipment Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 42

5.12 Johns Hopkins University Company Overview 43

5.12.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 43

5.13 Medisse BV (Inactive) Company Overview 44

5.13.1 Medisse BV (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 44

5.14 RetinaSense Company Overview 45

5.14.1 RetinaSense Pipeline Products & Ongoing Clinical Trials Overview 45

5.15 Synergetics USA, Inc. (Inactive) Company Overview 46

5.15.1 Synergetics USA, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 46

5.16 The Chinese University of Hong Kong Company Overview 47

5.16.1 The Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview 47

5.17 Tupai (Beijing) Medical Technology Co Ltd Company Overview 48

5.17.1 Tupai (Beijing) Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 48

5.18 University of Kansas Company Overview 49

5.18.1 University of Kansas Pipeline Products & Ongoing Clinical Trials Overview 49

5.19 University of Minnesota Company Overview 50

5.19.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 50

6 Vitreo Retinal Surgery Devices- Recent Developments 51

6.1 May 13, 2024: Alcon Reports Strong First-Quarter 2024 Results Driven by Robust Sales in Contact Lenses and Ocular Health 51

6.2 Apr 15, 2024: Bausch + Lomb Will Release First-Quarter 2024 Financial Results on May 1 52

6.3 Feb 27, 2024: Alcon’s Broad Portfolio Delivers Robust Sales and Earnings Growth in FY 2023 53

6.4 Feb 12, 2024: ABVC BioPharma Receives Australian Patent, Valid Until 2040, for Its Treatment of Major Depressive Disorder (MDD) 55

6.5 Oct 26, 2023: Pixium Vision Announces its Financial Results for H1 2023 and Provides Update 56

6.6 Oct 02, 2023: Zeiss and Boehringer Ingelheim Are Working Together on the Early Detection of Eye Diseases and the Prevention of Vision Loss 57

6.7 Aug 23, 2023: ABVC BioPharma Provides Updates on ADHD Phase IIb Clinical Study 58

6.8 Aug 15, 2023: Alcon Reports Second Quarter 2023 Results 58

6.9 Aug 03, 2023: ABVC Announces the Approval of the Plan for GMP Production Facilities of Vitargus by Taiwan Science Park Administration 64

6.10 Jul 13, 2023: Bausch Health to Announce Second-Quarter 2023 Results on Aug. 3 64

7 Appendix 66

7.1 Methodology 66

7.2 About GlobalData 69

7.3 Contact Us 69

7.4 Disclaimer 69

Table

Vitreo Retinal Surgery Devices – Pipeline Products by Stage of Development 10

Vitreo Retinal Surgery Devices – Pipeline Products by Territory 11

Vitreo Retinal Surgery Devices – Pipeline Products by Regulatory Path 12

Vitreo Retinal Surgery Devices – Pipeline Products by Estimated Approval Date 13

Vitreo Retinal Surgery Devices – Ongoing Clinical Trials 14

Vitreo Retinal Surgery Devices Companies – Pipeline Products by Stage of Development 15

Vitreo Retinal Surgery Devices – Pipeline Products by Stage of Development 16

ABVC BioPharma Inc Pipeline Products & Ongoing Clinical Trials Overview 17

Vitargus – Product Status 17

Vitargus – Product Description 17

AcuSurgical SAS Pipeline Products & Ongoing Clinical Trials Overview 18

Luca System – Product Status 18

Luca System – Product Description 18

AcuSurgical SAS – Ongoing Clinical Trials Overview 19

Luca System – A Prospective, Open-label, Single-center, Study of the AcuSurgical Luca System for Treatment of Vitreoretinal Diseases 20

Al.chi.mi.a. Srl Pipeline Products & Ongoing Clinical Trials Overview 21

Retinal Surgery Instrument – Product Status 21

Retinal Surgery Instrument – Product Description 21

Alcon Inc Pipeline Products & Ongoing Clinical Trials Overview 22

Finesse Reflex Handle – Product Status 22

Finesse Reflex Handle – Product Description 23

New CONSTELLATION Vitreoretinal System – Product Status 23

New CONSTELLATION Vitreoretinal System – Product Description 23

Next Generation Vitreo-retinal System – Product Status 24

Next Generation Vitreo-retinal System – Product Description 24

Next-Generation Phaco Vit-Ret Console – Product Status 24

Next-Generation Phaco Vit-Ret Console – Product Description 25

Ngenuity 2.0 – Product Status 25

Ngenuity 2.0 – Product Description 25

Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview 26

BLS – 009: Retina – Product Status 26

BLS – 009: Retina – Product Description 27

BLS-005: Retina – Product Status 27

BLS-005: Retina – Product Description 27

BLS-012: Retina – Product Status 27

BLS-012: Retina – Product Description 28

BLS-013: Retina – Product Status 28

BLS-013: Retina – Product Description 28

BLS-018: Retina – Product Status 29

BLS-018: Retina – Product Description 29

BLS-019: Retina – Product Status 29

BLS-019: Retina – Product Description 30

BLS-020: Retina – Product Status 30

BLS-020: Retina – Product Description 30

BLS-021: Retina – Product Status 30

BLS-021: Retina – Product Description 31

BLS-022: Retina – Product Status 31

BLS-022: Retina – Product Description 31

BLS-023: Retina – Product Status 31

BLS-023: Retina – Product Description 32

BLS-024: Retina – Product Status 32

BLS-024: Retina – Product Description 32

BLS-025: Retina – Product Status 33

BLS-025: Retina – Product Description 33

BLS-026: Retina – Product Status 33

BLS-026: Retina – Product Description 33

BLS-027: Retina – Product Status 34

BLS-027: Retina – Product Description 34

BLS-028: Retina – Product Status 34

BLS-028: Retina – Product Description 34

BLS-029: Retina – Product Status 35

BLS-029: Retina – Product Description 35

BLS-030: Retina – Product Status 35

BLS-030: Retina – Product Description 35

BLS-031: Retina – Product Status 36

BLS-031: Retina – Product Description 36

Beaver-Visitec International Inc Pipeline Products & Ongoing Clinical Trials Overview 37

Velvet – Product Status 37

Velvet – Product Description 37

Boston College Pipeline Products & Ongoing Clinical Trials Overview 38

Visual Prosthetic Device – Product Status 38

Visual Prosthetic Device – Product Description 38

Cambridge Polymer Group Inc Pipeline Products & Ongoing Clinical Trials Overview 39

Retinal Tamponade – Product Status 39

Retinal Tamponade – Product Description 39

Carnegie Mellon University Pipeline Products & Ongoing Clinical Trials Overview 40

Micron – Product Status 40

Micron – Product Description 40

Duke University Pipeline Products & Ongoing Clinical Trials Overview 41

Secure Locking Cannula – Product Status 41

Secure Locking Cannula – Product Description 41

Hangzhou Xiran Medical Equipment Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 42

Genesis – Product Status 42

Genesis – Product Description 42

Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 43

Microsurgical Tool – Product Status 43

Microsurgical Tool – Product Description 43

Medisse BV (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 44

PTMC Scleral Buckle – Product Status 44

PTMC Scleral Buckle – Product Description 44

RetinaSense Pipeline Products & Ongoing Clinical Trials Overview 45

RetinaSense Device – Product Status 45

RetinaSense Device – Product Description 45

Synergetics USA, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 46

Intraoperative Device – Product Status 46

Intraoperative Device – Product Description 46

The Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview 47

Scleral Buckles – Product Status 47

Scleral Buckles – Product Description 47

Tupai (Beijing) Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 48

Ultra-Milk Vitrectomy Machine – Product Status 48

Ultra-Milk Vitrectomy Machine – Product Description 48

University of Kansas Pipeline Products & Ongoing Clinical Trials Overview 49

Subretinal Fluid Drainage Cannula – Product Status 49

Subretinal Fluid Drainage Cannula – Product Description 49

University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 50

Scleral Depressor System – Product Status 50

Scleral Depressor System – Product Description 50

Glossary 68

Figures

Vitreo Retinal Surgery Devices – Pipeline Products by Stage of Development 10

Vitreo Retinal Surgery Devices – Pipeline Products by Territory 11

Vitreo Retinal Surgery Devices – Pipeline Products by Regulatory Path 12

Vitreo Retinal Surgery Devices – Pipeline Products by Estimated Approval Date 13

Vitreo Retinal Surgery Devices – Ongoing Clinical Trials 14

Frequently asked questions

Vitreo Retinal Surgery Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

Most Popular
$8,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Vitreo Retinal Surgery Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Vitreo Retinal Surgery Devices reports
Medical Devices
New
CAD/CAM Systems and Materials Market Size by Segments, Share, Regulatory,…
$7,500 | August 2026
Medical Devices
New
Dental Handpieces Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | August 2026
Medical Devices
New
Topical Absorbable Hemostats Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | August 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Vitreo Retinal Surgery Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Vitreo Retinal Surgery Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more